Moving Antimicrobial Stewardship Forward in Special Population Settings, ESCMID Postgraduate Education Course

5 - 6 November 2015, Ferney-Voltaire, France

  • ESCMID Study Group for Infections in the Elderly (ESGIE)
  • ESCMID Study Group for Antibiotic Policies (ESGAP)
  • ESCMID PK/PD of Anti-Infectives Study Group (EPASG)
  • Annecy-Genevois Hospital Centre (CHANGE)
  • Societé de Pathologie Infectieuse de Langue Française (SPILF)
Course Coordinator

William Couet, Poitiers, France

Course Objectives
  • To broaden the concept of antimicrobial stewardship for specific patient settings, where appropriate dose and dosing should be performed according to peculiar characteristics.
  • To better understand the meaning of colonization by MDRO and how to manage them according to their resistance mechanism with the best antimicrobial with the least selection pressure.
  • To provide to ID specialists a scenario of future challenges of antimicrobial stewardship.
Course Venue

Appart'Hotel Odalys City Ferney
13 Chemin du Levant
01210 Ferney-Voltaire

Target Audience

30–50 ID specialists, geriatricians and physicians in charge of antimicrobial stewardship programmes within health institutions.

Contact Person (Scientific Programme)

Prof William Couet
School of Medicine and Pharmacy
University of Poitiers
Inserm U-1070 “Pharmacologie des Anti-Infectieux”
Pôle Biologie Santé
1 rue Georges Bonnet-BP 633
86022 Poitiers

Phone +33 549 454 379
Fax +33 549 454 378

Administrative Secretariat

Sylvie Landier
30 Bd Pasteur
75015 Paris

Phone +33 153 581 436
Fax +33 153 581 405

Course Topics

Presentations are availabe in the ESCMID Online Lecture Library.

  • The inner microbiome and its impact on what we can do with antimicrobials
  • Building a better mousetrap for pathogens through resistance mechanism knowledge
  • Should we treat colonization by MDRO?
  • What are the implications of altered pharmacokinetics in an ageing body for drug interactions: outcome and safety
  • Best therapy of healthcare-associated pneumonia: narrow vs. broad spectrum antimicrobials?
  • If renal replacement therapies affect antimicrobial concentrations, how can we optimize therapy?
  • Treating infections in obese patients: where one size does absolutely not fit all
  • The ever wider use of systemic anti-fungals: implications for stewardship
  • Strategies and challenges of antimicrobial stewardship in long-term care institutions
  • Rejuvenating oral antimicrobials for the treatment of severe infections: PK/PD and safety considerations
  • Improving antibiotic policy through PK/PD-driven prescription
  • Clostridium difficile as an indicator of effective antimicrobial stewardship
  • The convergent lines of improved antimicrobial stewardship and implementation of science/behavioural changes
  • New technologies and tools that ensure efficiency of antimicrobial stewardship programmes
  • Computerized decision support–can it replace antibiotic stewardship programmes?
  • Round table with conveners and discussion of future projects
Invited Faculty Members
  • Antoine Andremont, Paris, France
  • Richard Aschbacher, Bolzano, Italy
  • Bojana Beovic, Ljubljana, Slovenia
  • Jean-Pierre Bru, Annecy, France
  • William Couet, Poitiers, France
  • Uwe Frank, Freiburg, Germany
  • Leonard Leibovici, Petah-Tiqva, Israel
  • Leonardo Pagani, Geneva, Switzerland
  • Mical Paul, Haifa, Israel
  • José Ramon Pano Pardo, Zaragoza, Spain
  • Federico Pea, Udine, Italy
  • Céline Pulcini, Nancy, France
  • Jason Roberts, Brisbane, Australia
  • Markus Ruhnke, Berlin, Germany
  • Pierluigi Viale, Bologna, Italy